Piekos Brian 4
4 · Gemini Therapeutics, Inc. /DE · Filed Jun 2, 2022
Insider Transaction Report
Form 4
Piekos Brian
Chief Financial Officer
Transactions
- Award
Common Stock
2022-05-31$1.09/sh+9,960$10,856→ 17,615 total
Footnotes (2)
- [F1]These shares were acquired under the Gemini Therapeutics, Inc. 2021 Employee Stock Purchase Plan ("ESPP").
- [F2]In accordance with the terms of the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on May 31, 2022.